source
- Immunotherapy trials like PODIUM-303 are reshaping treatment for squamous cell anal cancer, says Dr ParikhDr Aparna R. Parikh, an oncologist at Massachusetts General Hospital and Harvard professor, highlighted the growing feasibility of immunotherapy studies in squamous cell anal carcinoma (SCAC). She…
- Neoadjuvant immunotherapy gaining favor for metastatic melanoma, says Dr. SznolDr. Mario Sznol discussed current guidance on using neoadjuvant therapy for patients with advanced melanoma. Patients who have active nodal disease detected by imaging or physical exam are now vie…